AtaiBeckley surges after report says Lilly is nearing buyout deal

AtaiBeckley

16/07/2026 10:12

 ** Shares of psychedelic drugmaker AtaiBeckley ATAI.O jump 51% to $8.12 in premarket trading
** Bloomberg News reports late on Wednesday pharma giant Eli Lilly LLY.N nears deal to buy co, negotiating at a premium
** ATAI's focus is on psychedelic-based treatments with a nasal spray for treatment-resistant depression under development 
** ATAI stands at a market capitalization of $1.97 bln as of last close, per LSEG data
** All 15 brokerages covering ATAI stock rate it "buy" or higher; their median PT is $14 - LSEG data 
** Up to last close, the stock is up 31% YTD 

 (Reporting by Sudeshna Ghoshal in Bengaluru)
 ((Sudeshna.Ghoshal@thomsonreuters.com;))